REPLIGEN CORP FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits
(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
On June 10, 2014, Nicolas M. Barthelemy was elected to the Board of Directors
(the "Board") of Repligen Corporation (the "Company"). Mr. Barthelemy most
recently served as President, Global Commercial Operations at Life Technologies,
which position he held from early 2011 until the acquisition of Life
Technologies by Thermo Fisher Scientific Corporation in 2013.
Mr. Barthelemy will receive cash and equity compensation pursuant to the
Company's non-employee director compensation policy as set forth in the
Company's Amended and Restated Director Compensation Policy (the "Director
Compensation Policy"). Pursuant to the terms of the Director Compensation
Policy, Mr. Barthelemy received an option to purchase 24,000 shares of Common
Stock on the date he joined the Board (the "Initial Board Option"). The Initial
Board Option vests equally over a three-year period from the date of grant. The
Initial Board Option has a term of ten years, subject to early termination in
the event of death, removal or resignation from the Board. The Initial Board
Option has an exercise price equal to the closing price of the stock on the date
the Initial Board Option is granted. In addition, under the Director
Compensation Policy, each non-employee director receives an annual retainer for
service on the Board and committees of the Board, and except in the year
following a non-employee director's first election to the Board by the
stockholders, each non-employee director reelected to the Board by the
stockholders is awarded annually restricted stock units.
There are no arrangements or understandings between Mr. Barthelemy and any other
persons pursuant to which Mr. Barthelemy was selected as a director. There have
been no transactions since the beginning of the Company's last fiscal year, or
any currently proposed transaction, in which the Company was or is to be a
participant, in which the amount involved exceeds $120,000, and in which
Mr. Barthelemy had, or will have, a direct or indirect material interest.
The Company has issued a press release announcing Mr. Barthelemy's election to
the Board and has attached a copy of such press release as Exhibit 99.1 hereto.
Item 9.01. Financial Statements and Exhibits.
99.1 Press Release by Repligen Corporation, dated June 12, 2014.
[ Back To TMCnet.com's Homepage ]